Systemic lupus erythematosus in Tunisia: Demographic and clinical analysis of 100 patients

Lupus

Volumn 13, Issue 3, 2004, Pages 204-211

  Houman, M Habib ^a   Smiti Khanfir, M ^a   Ghorbell, I Ben ^a   Miled, M ^a  

^a LA RABTA HOSPITAL   (Tunisia)

Author keywords

Arab African; Autoantibodies; Demographics; Nephritis; Outcome; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GEOGRAPHIC DISTRIBUTION; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; LABORATORY TEST; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROPSYCHIATRY; ONSET AGE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; TREATMENT OUTCOME; TUNISIA;

EID: 1842782573     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203303lu530xx     Document Type: Article

References (39)

1. Alarcon GS, Friedman AW, Straaton KV et al. Systemic lupus erythematosus in three ethnic groups: III A comparison of characteristics early in the natural history of the LUMINA cohort. Lupus 1999; 8: 197-209.
2. Hopkinson ND, Doherty M, Powell RJ. Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients. Ann Rheum Dis 1994; 53: 675-680.
3. Thumboo J, Fong KY, Chng HH et al. The effects of ethnicity on disease patterns in 472 orientals with systemic lupus erythematosus. J Rheumatol 1998; 25: 1299-1304.
4. Smith EL, Rhmerling S. The American College of Rheumatology criteria for the classification of systemic lupus erythematosus. Strengths, weaknesses and opportunities for improvement. Lupus 1999; 8: 586-595.
5. American Rheumatism Association glossary committee. Signs and symptoms. Dictionary of the Rheumatic Disease 1982; 1: 1-80.
6. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-640.
7. Ballou SP, Khan MA, Kushner I. Clinical features of systemic lupus erythematosus - differences related to race and age onset. Arthritis Rheum 1982; 25: 55-60.
8. Ka MM, Diallo S, Kane A et al. Systemic lupus erythematosus and lupus syndromes in Senegal. A retrospective study of 30 patients seen over 10 years. Rev Rheum Engl Ed 1998; 65: 471-476.
9. Alballa SR. Systemic lupus erythematosus in Saudi patients. Clin Rheumatol 1995; 14: 342-346.
10. Al-Rawi ZS, Al Shaarbaf H, Al Rabeem E, Khalifa ST. Clinical features of early cases of systemic lupus erythematosus in Iraqi patients. Br J Rheumatol 1983; 22: 165-171.
11. Uthman I, Nasr F, Kassak K, Masri A. Systemic lupus erythematosus in Lebanon. Lupus 1999; 8: 713-715.
12. Al-Jarallah K, Al-Awadi A, Siddiqui H et al. Systemic lupus erythematosus in Kuwait - hospital based study. Lupus 1998; 7: 434-438.
13. Al-Maini MH, El-Ageb EM, Al-Wahaibi SS, Al-Farsi Y, Richens ER. Demographic, autoimmune, and clinical profiles of patients with systemic lupus erythematosus in Oman. Rheumatol Int 2003; 23: 186-191.
14. Phan JC, Bush TM, Donald F, Ward M. Clinical and laboratory features of patients of Vietnamese descent with systemic lupus erythematosus. Lupus 1999; 8: 521-524.
15. Habib GS, Saliba WR. Systemic lupus erythematosus among Arabs. IMAJ 2002; 4: 690-693.
16. Tickly M, Burgin S, Mohanlal P, Belligan A, George J. Auto antibodies in black South African with systemic lupus erythematosus: Spectrum and clinical associations. Clin Rheumatol 1996; 15: 261-265.
17. Yokohari R, Tsunematsu T. Application to Japanese patients of the 1982 American Rheumatism Association revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1995; 28: 693-698.
18. Cervera R, and the European Working Party on Systemic Lupus Erythematosus. Lessons from the "Euro-Lupus Cohort". Ann Med Interne 2002; 153: 530-536.
19. Wallace DJ, Podell T, Weiner J et al. Systemic lupus erythematosus - survival patterns. Experience with 609 patients. JAMA 1981; 245: 934-938.
20. Dooley MA, Falk RJ. Immunosuppressive therapy of lupus nephritis. Lupus 1998; 7: 630-634.
21. Le Thi Huong D, Papo T, Beaufils H et al. Renal involvement in systemic lupus erythematosus: a study of 180 patients from a single center. Medicine 1999; 78: 148-166.
22. Pisetsky DS, Wallace DJ, Nessim S, Metzger AI, Klinenberg JR. Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum 1991; 21: 55-64.
23. Omdal R. Some controversies of neuropsychiatric systemic lupus erythematosus. Scand J Rheumatol 2002; 31: 192-197.
24. Afeltra A, Garzia P, Mitterhofer AP et al. Neuropsychiatric lupus syndromes: Relationship with antiphospholipid antibodies. Neurology 2003; 61: 108-110.
25. Sanna G, Bertolaccini ML, Cuadrado MJ et al. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 2003; 30: 985-992.
26. Mok CC, Lau CS, Wong RW. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus. J Rheumatol 2001; 28: 766-771.
27. Boey ML, Peebles CL, Tsay G, Feng PH, Tan EM. Clinical and autoantibody correlations in orientals with systemic lupus erythematosus. Ann Rheum Dis 1988; 47: 918-923.
28. Molina JF, Molina J, Garcia C, Gharafi AE, Wilson WA, Esponisa LR. Ethnic differences in the clinical expression of systemic lupus erythematosus: a comparative study between African-Americans and Latin Americans. Lupus 1997; 6: 63-67.
29. Arnett FC, Hamilton RG, Roebber MG, Harley JB, Reichlin M. Increased frequencies of Sm and nRNP autoantibodies in American blacks compared to whites with systemic lupus erythematosus. J Rheumatol 1988; 15: 1773-1776.
30. Zimmermann AF, de Messias IJ, Utiyama SR et al. Clinical, autoimmune and demographic profile in systemic lupus erythematosus (SLE) patients from southern Brazil. J Investig Allergol Clin Immunol 1997; 7: 24-31.
31. Alarcon-Segovia D, Deleze M, Oria CV et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine 1989; 68: 353-365.
32. 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4120-4124.
33. Galli M, Confurius P, Maassen C et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma cofactor. Lancet 1990; 335: 1544-1547.
34. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990; 336: 177-178.
35. Tsutsumi A, Matsuura E, Ichikawa K et al. Antibodies to β2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus. Arthritis Rheum 1996; 39: 1466-1474.
36. Loizou S, Samarkos M, Norsworthy PJ, Cazabon JK, Walport J, Davies KA. Significance of anticardiolipin and anti-β2-glycoprotein I antibodies in lupus nephritis. Rheumatology 2000; 39: 962-968.
37. Ward MM, Polisson RP. A meta-analysis of the clinical manifestations of older-onset systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1226-1232.
38. Mak SK, Lam EKM, Wong AKM. Clinical profile of patients with late-onset SLE: not a benign subgroup. Lupus 1998; 7: 23-28.
39. Ho CTK, Mok CC, Lau CS, Wong RWS. Late onset systemic lupus erythematosus in southern Chinese. Ann Rheum Dis 1998; 57: 437-440.